Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Xenon Pharmaceuticals' flunarizine granted FDA orphan designation » 18:09
05/12/21
05/12
18:09
05/12/21
18:09
XENE

Xenon Pharmaceuticals

$17.63 /

-0.36 (-2.00%)

According to a post on…

According to a post on the FDA's website, Xenon Pharmaceuticals' treatment of childhood Absence Epilepsy, flunarizine, was granted FDA orphan designation. Reference Link

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$17.63 /

-0.36 (-2.00%)

XENE Xenon Pharmaceuticals
$17.63 /

-0.36 (-2.00%)

10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
07/21/20
Fly Intel: Top five analyst initiations
07/21/20 Needham
Xenon Pharmaceuticals initiated with a Buy at Needham
XENE Xenon Pharmaceuticals
$17.63 /

-0.36 (-2.00%)

  • 10
    Mar
XENE Xenon Pharmaceuticals
$17.63 /

-0.36 (-2.00%)

Earnings
Xenon Pharmaceuticals reports Q1 EPS (42c) vs. (22c) last year » 16:05
05/11/21
05/11
16:05
05/11/21
16:05
XENE

Xenon Pharmaceuticals

$17.98 /

-0.18 (-0.99%)

Reports Q1 revenue…

Reports Q1 revenue $4.36M, consensus $5.15M. Simon Pimstone, Xenon's CEO, said, "We continue to make excellent progress across both our proprietary and partnered programs. In particular, I am pleased to report that we have completed patient screening in our Phase 2b 'X-TOLE' clinical trial evaluating XEN1101 as an adjunctive treatment of focal epilepsy. With the final patients currently in baseline, we anticipate randomization to be completed in June and the release of topline data by the end of the third quarter. Additionally, we continue to initiate new sites to support ongoing patient enrollment in our Phase 3 "EPIK" study, which is evaluating XEN496 as a treatment of KCNQ2 developmental and epileptic encephalopathy."

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$17.98 /

-0.18 (-0.99%)

XENE Xenon Pharmaceuticals
$17.98 /

-0.18 (-0.99%)

10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
07/21/20
Fly Intel: Top five analyst initiations
07/21/20 Needham
Xenon Pharmaceuticals initiated with a Buy at Needham
  • 10
    Mar
XENE Xenon Pharmaceuticals
$17.98 /

-0.18 (-0.99%)

Conference/Events
Stifel to hold a virtual conference » 04:55
04/01/21
04/01
04:55
04/01/21
04:55
SAGE

Sage Therapeutics

$74.85 /

+1.82 (+2.49%)

, PRAX

Praxis Precision Medicines

$32.86 /

+3.25 (+10.98%)

, CERE

Cerevel Therapeutics

$13.73 /

+1.36 (+10.99%)

, KRTX

Karuna Therapeutics

$119.93 /

+2.66 (+2.27%)

, PASG

Passage Bio

$17.55 /

+0.8 (+4.78%)

, TSHA

Taysha Gene Therapies

$20.21 /

-0.33 (-1.61%)

, BIIB

Biogen

$280.05 /

+4.17 (+1.51%)

, XENE

Xenon Pharmaceuticals

$17.94 /

+0.59 (+3.40%)

, STOK

Stoke Therapeutics

$38.92 /

+1.89 (+5.10%)

, ZGNX

Zogenix

$19.52 /

+0.33 (+1.72%)

, AVDL

Avadel Pharmaceuticals

$9.11 /

+0.28 (+3.17%)

, QURE

uniQure

$33.75 /

+0.53 (+1.60%)

Stifel Virtual CNS Day…

Stifel Virtual CNS Day 2021 will be held on March 31-April 1.

ShowHide Related Items >><<
ZGNX Zogenix
$19.52 /

+0.33 (+1.72%)

XENE Xenon Pharmaceuticals
$17.94 /

+0.59 (+3.40%)

TSHA Taysha Gene Therapies
$20.21 /

-0.33 (-1.61%)

STOK Stoke Therapeutics
$38.92 /

+1.89 (+5.10%)

SAGE Sage Therapeutics
$74.85 /

+1.82 (+2.49%)

QURE uniQure
$33.75 /

+0.53 (+1.60%)

PRAX Praxis Precision Medicines
$32.86 /

+3.25 (+10.98%)

PASG Passage Bio
$17.55 /

+0.8 (+4.78%)

KRTX Karuna Therapeutics
$119.93 /

+2.66 (+2.27%)

CERE Cerevel Therapeutics
$13.73 /

+1.36 (+10.99%)

BIIB Biogen
$280.05 /

+4.17 (+1.51%)

AVDL Avadel Pharmaceuticals
$9.11 /

+0.28 (+3.17%)

SAGE Sage Therapeutics
$74.85 /

+1.82 (+2.49%)

02/26/21 Mizuho
Sage Therapeutics downgraded to Neutral from Buy at Mizuho
02/25/21 Oppenheimer
Sage Therapeutics price target raised to $102 from $90 at Oppenheimer
02/25/21 H.C. Wainwright
Sage Therapeutics price target raised to $86 from $74 at H.C. Wainwright
02/24/21 Stifel
Stifel cuts Sage target to $121, reiterates Buy after quarterly results
PRAX Praxis Precision Medicines
$32.86 /

+3.25 (+10.98%)

03/17/21 Piper Sandler
Piper sees 114 IND, pivotal trial as sign of Praxis regulatory capabilities
01/21/21 Wedbush
Praxis Precision Medicines price target raised to $61 from $51 at Wedbush
11/17/20 Piper Sandler
Praxis Precision clinical hold looks like 'formality,' says Piper Sandler
11/11/20
Fly Intel: Top five analyst initiations
CERE Cerevel Therapeutics
$13.73 /

+1.36 (+10.99%)

12/10/20 Goldman Sachs
Cerevel Therapeutics initiated with a Buy at Goldman Sachs
11/23/20 Jefferies
Cerevel Therapeutics initiated with a Buy at Jefferies
11/09/20
Fly Intel: Top five analyst initiations
11/09/20 Stifel
Cerevel Therapeutics initiated with a Buy at Stifel
KRTX Karuna Therapeutics
$119.93 /

+2.66 (+2.27%)

03/22/21 BofA
Karuna Therapeutics initiated with a Buy at BofA
03/01/21 Oppenheimer
Karuna Therapeutics price target raised to $148 from $135 at Oppenheimer
02/26/21 Mizuho
Karuna Therapeutics price target raised to $150 from $116 at Mizuho
02/26/21 JMP Securities
Karuna Therapeutics price target raised to $167 from $122 at JMP Securities
PASG Passage Bio
$17.55 /

+0.8 (+4.78%)

03/08/21 Chardan
Passage Bio price target raised to $45 from $35 at Chardan
03/04/21 Citi
Citi remains buyer of Passage Bio into first clinical data
03/04/21 Goldman Sachs
Passage Bio upgraded to Buy from Neutral at Goldman Sachs
02/04/21
Fly Intel: Top five analyst initiations
TSHA Taysha Gene Therapies
$20.21 /

-0.33 (-1.61%)

03/04/21 Chardan
Taysha Gene Therapies price target raised to $60 from $45 at Chardan
02/23/21 William Blair
William Blair starts Taysha with Outperform, $46 fair-value estimate
02/23/21 William Blair
William Blair starts Taysha Gene Therapies with Outperform on positive FDA draft
02/23/21 William Blair
Taysha Gene Therapies initiated with an Outperform at William Blair
BIIB Biogen
$280.05 /

+4.17 (+1.51%)

03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/25/21 Mizuho
Two 'low probability' Biogen events could drive upside, says Mizuho
03/23/21 Piper Sandler
Neurologist survey shows erosion for Biogen franchises, says Piper Sandler
02/17/21 Cantor Fitzgerald
Biogen price target lowered to $268 from $278 at Cantor Fitzgerald
XENE Xenon Pharmaceuticals
$17.94 /

+0.59 (+3.40%)

10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
07/21/20
Fly Intel: Top five analyst initiations
07/21/20 Needham
Xenon Pharmaceuticals initiated with a Buy at Needham
STOK Stoke Therapeutics
$38.92 /

+1.89 (+5.10%)

03/29/21 Canaccord
Stoke Therapeutics weakness a buying opportunity, says Canaccord
03/11/21 Canaccord
Stoke Therapeutics price target raised to $76 from $72 at Canaccord
03/10/21 Credit Suisse
Stoke Therapeutics price target raised to $58 from $49 at Credit Suisse
02/10/21 Wedbush
Stoke Therapeutics downgraded to Neutral at Wedbush
ZGNX Zogenix
$19.52 /

+0.33 (+1.72%)

02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
08/24/20 Raymond James
Zogenix initiated with a Market Perform at Raymond James
07/15/20 Stifel
Physician survey suggests Zogenix shares undervalued, says Stifel
AVDL Avadel Pharmaceuticals
$9.11 /

+0.28 (+3.17%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
QURE uniQure
$33.75 /

+0.53 (+1.60%)

03/29/21 H.C. Wainwright
uniQure probe 'important first step' toward lifting hold, says H.C. Wainwright
03/02/21 Chardan
uniQure price target raised to $100 from $85 at Chardan
12/22/20 Chardan
uniQure selloff on clinical hold brings good entry point, says Chardan
12/22/20 Jefferies
uniQure's EtranaDez unlikely to raise HCC risk in hemB patients, says Jefferies
ZGNX Zogenix
$19.52 /

+0.33 (+1.72%)

XENE Xenon Pharmaceuticals
$17.94 /

+0.59 (+3.40%)

TSHA Taysha Gene Therapies
$20.21 /

-0.33 (-1.61%)

STOK Stoke Therapeutics
$38.92 /

+1.89 (+5.10%)

SAGE Sage Therapeutics
$74.85 /

+1.82 (+2.49%)

QURE uniQure
$33.75 /

+0.53 (+1.60%)

PRAX Praxis Precision Medicines
$32.86 /

+3.25 (+10.98%)

PASG Passage Bio
$17.55 /

+0.8 (+4.78%)

KRTX Karuna Therapeutics
$119.93 /

+2.66 (+2.27%)

CERE Cerevel Therapeutics
$13.73 /

+1.36 (+10.99%)

BIIB Biogen
$280.05 /

+4.17 (+1.51%)

AVDL Avadel Pharmaceuticals
$9.11 /

+0.28 (+3.17%)

  • 10
    Mar
  • 02
    Mar
  • 22
    Jan
  • 20
    Nov
  • 16
    Oct
  • 24
    Sep
  • 29
    Apr
BIIB Biogen
$280.05 /

+4.17 (+1.51%)

ZGNX Zogenix
$19.52 /

+0.33 (+1.72%)

XENE Xenon Pharmaceuticals
$17.94 /

+0.59 (+3.40%)

STOK Stoke Therapeutics
$38.92 /

+1.89 (+5.10%)

SAGE Sage Therapeutics
$74.85 /

+1.82 (+2.49%)

QURE uniQure
$33.75 /

+0.53 (+1.60%)

PRAX Praxis Precision Medicines
$32.86 /

+3.25 (+10.98%)

PASG Passage Bio
$17.55 /

+0.8 (+4.78%)

KRTX Karuna Therapeutics
$119.93 /

+2.66 (+2.27%)

CERE Cerevel Therapeutics
$13.73 /

+1.36 (+10.99%)

BIIB Biogen
$280.05 /

+4.17 (+1.51%)

AVDL Avadel Pharmaceuticals
$9.11 /

+0.28 (+3.17%)

ZGNX Zogenix
$19.52 /

+0.33 (+1.72%)

PRAX Praxis Precision Medicines
$32.86 /

+3.25 (+10.98%)

PASG Passage Bio
$17.55 /

+0.8 (+4.78%)

BIIB Biogen
$280.05 /

+4.17 (+1.51%)

Conference/Events
Stifel to hold a virtual conference » 10:20
03/31/21
03/31
10:20
03/31/21
10:20
SAGE

Sage Therapeutics

$75.75 /

+2.72 (+3.72%)

, PRAX

Praxis Precision Medicines

$29.13 /

-0.48 (-1.62%)

, CERE

Cerevel Therapeutics

$13.49 /

+1.12 (+9.05%)

, KRTX

Karuna Therapeutics

$119.05 /

+1.78 (+1.52%)

, PASG

Passage Bio

$17.40 /

+0.65 (+3.88%)

, TSHA

Taysha Gene Therapies

$20.40 /

-0.14 (-0.68%)

, BIIB

Biogen

$276.92 /

+1.04 (+0.38%)

, XENE

Xenon Pharmaceuticals

$17.60 /

+0.25 (+1.44%)

, STOK

Stoke Therapeutics

$39.00 /

+1.97 (+5.32%)

, ZGNX

Zogenix

$19.38 /

+0.19 (+0.99%)

, AVDL

Avadel Pharmaceuticals

$9.00 /

+0.17 (+1.93%)

, QURE

uniQure

$34.10 /

+0.88 (+2.65%)

Stifel Virtual CNS Day…

Stifel Virtual CNS Day 2021 will be held on March 31-April 1.

ShowHide Related Items >><<
ZGNX Zogenix
$19.38 /

+0.19 (+0.99%)

XENE Xenon Pharmaceuticals
$17.60 /

+0.25 (+1.44%)

TSHA Taysha Gene Therapies
$20.40 /

-0.14 (-0.68%)

STOK Stoke Therapeutics
$39.00 /

+1.97 (+5.32%)

SAGE Sage Therapeutics
$75.75 /

+2.72 (+3.72%)

QURE uniQure
$34.10 /

+0.88 (+2.65%)

PRAX Praxis Precision Medicines
$29.13 /

-0.48 (-1.62%)

PASG Passage Bio
$17.40 /

+0.65 (+3.88%)

KRTX Karuna Therapeutics
$119.05 /

+1.78 (+1.52%)

CERE Cerevel Therapeutics
$13.49 /

+1.12 (+9.05%)

BIIB Biogen
$276.92 /

+1.04 (+0.38%)

AVDL Avadel Pharmaceuticals
$9.00 /

+0.17 (+1.93%)

SAGE Sage Therapeutics
$75.75 /

+2.72 (+3.72%)

02/26/21 Mizuho
Sage Therapeutics downgraded to Neutral from Buy at Mizuho
02/25/21 Oppenheimer
Sage Therapeutics price target raised to $102 from $90 at Oppenheimer
02/25/21 H.C. Wainwright
Sage Therapeutics price target raised to $86 from $74 at H.C. Wainwright
02/24/21 Stifel
Stifel cuts Sage target to $121, reiterates Buy after quarterly results
PRAX Praxis Precision Medicines
$29.13 /

-0.48 (-1.62%)

03/17/21 Piper Sandler
Piper sees 114 IND, pivotal trial as sign of Praxis regulatory capabilities
01/21/21 Wedbush
Praxis Precision Medicines price target raised to $61 from $51 at Wedbush
11/17/20 Piper Sandler
Praxis Precision clinical hold looks like 'formality,' says Piper Sandler
11/11/20
Fly Intel: Top five analyst initiations
CERE Cerevel Therapeutics
$13.49 /

+1.12 (+9.05%)

12/10/20 Goldman Sachs
Cerevel Therapeutics initiated with a Buy at Goldman Sachs
11/23/20 Jefferies
Cerevel Therapeutics initiated with a Buy at Jefferies
11/09/20
Fly Intel: Top five analyst initiations
11/09/20 Stifel
Cerevel Therapeutics initiated with a Buy at Stifel
KRTX Karuna Therapeutics
$119.05 /

+1.78 (+1.52%)

03/22/21 BofA
Karuna Therapeutics initiated with a Buy at BofA
03/01/21 Oppenheimer
Karuna Therapeutics price target raised to $148 from $135 at Oppenheimer
02/26/21 Mizuho
Karuna Therapeutics price target raised to $150 from $116 at Mizuho
02/26/21 JMP Securities
Karuna Therapeutics price target raised to $167 from $122 at JMP Securities
PASG Passage Bio
$17.40 /

+0.65 (+3.88%)

03/08/21 Chardan
Passage Bio price target raised to $45 from $35 at Chardan
03/04/21 Citi
Citi remains buyer of Passage Bio into first clinical data
03/04/21 Goldman Sachs
Passage Bio upgraded to Buy from Neutral at Goldman Sachs
02/04/21
Fly Intel: Top five analyst initiations
TSHA Taysha Gene Therapies
$20.40 /

-0.14 (-0.68%)

03/04/21 Chardan
Taysha Gene Therapies price target raised to $60 from $45 at Chardan
02/23/21 William Blair
William Blair starts Taysha with Outperform, $46 fair-value estimate
02/23/21 William Blair
William Blair starts Taysha Gene Therapies with Outperform on positive FDA draft
02/23/21 William Blair
Taysha Gene Therapies initiated with an Outperform at William Blair
BIIB Biogen
$276.92 /

+1.04 (+0.38%)

03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/25/21 Mizuho
Two 'low probability' Biogen events could drive upside, says Mizuho
03/23/21 Piper Sandler
Neurologist survey shows erosion for Biogen franchises, says Piper Sandler
02/17/21 Cantor Fitzgerald
Biogen price target lowered to $268 from $278 at Cantor Fitzgerald
XENE Xenon Pharmaceuticals
$17.60 /

+0.25 (+1.44%)

10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
07/21/20
Fly Intel: Top five analyst initiations
07/21/20 Needham
Xenon Pharmaceuticals initiated with a Buy at Needham
STOK Stoke Therapeutics
$39.00 /

+1.97 (+5.32%)

03/29/21 Canaccord
Stoke Therapeutics weakness a buying opportunity, says Canaccord
03/11/21 Canaccord
Stoke Therapeutics price target raised to $76 from $72 at Canaccord
03/10/21 Credit Suisse
Stoke Therapeutics price target raised to $58 from $49 at Credit Suisse
02/10/21 Wedbush
Stoke Therapeutics downgraded to Neutral at Wedbush
ZGNX Zogenix
$19.38 /

+0.19 (+0.99%)

02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
08/24/20 Raymond James
Zogenix initiated with a Market Perform at Raymond James
07/15/20 Stifel
Physician survey suggests Zogenix shares undervalued, says Stifel
AVDL Avadel Pharmaceuticals
$9.00 /

+0.17 (+1.93%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
QURE uniQure
$34.10 /

+0.88 (+2.65%)

03/29/21 H.C. Wainwright
uniQure probe 'important first step' toward lifting hold, says H.C. Wainwright
03/02/21 Chardan
uniQure price target raised to $100 from $85 at Chardan
12/22/20 Chardan
uniQure selloff on clinical hold brings good entry point, says Chardan
12/22/20 Jefferies
uniQure's EtranaDez unlikely to raise HCC risk in hemB patients, says Jefferies
ZGNX Zogenix
$19.38 /

+0.19 (+0.99%)

XENE Xenon Pharmaceuticals
$17.60 /

+0.25 (+1.44%)

TSHA Taysha Gene Therapies
$20.40 /

-0.14 (-0.68%)

STOK Stoke Therapeutics
$39.00 /

+1.97 (+5.32%)

SAGE Sage Therapeutics
$75.75 /

+2.72 (+3.72%)

QURE uniQure
$34.10 /

+0.88 (+2.65%)

PRAX Praxis Precision Medicines
$29.13 /

-0.48 (-1.62%)

PASG Passage Bio
$17.40 /

+0.65 (+3.88%)

KRTX Karuna Therapeutics
$119.05 /

+1.78 (+1.52%)

CERE Cerevel Therapeutics
$13.49 /

+1.12 (+9.05%)

BIIB Biogen
$276.92 /

+1.04 (+0.38%)

AVDL Avadel Pharmaceuticals
$9.00 /

+0.17 (+1.93%)

  • 10
    Mar
  • 02
    Mar
  • 22
    Jan
  • 20
    Nov
  • 16
    Oct
  • 24
    Sep
  • 29
    Apr
BIIB Biogen
$276.92 /

+1.04 (+0.38%)

ZGNX Zogenix
$19.38 /

+0.19 (+0.99%)

XENE Xenon Pharmaceuticals
$17.60 /

+0.25 (+1.44%)

STOK Stoke Therapeutics
$39.00 /

+1.97 (+5.32%)

SAGE Sage Therapeutics
$75.75 /

+2.72 (+3.72%)

QURE uniQure
$34.10 /

+0.88 (+2.65%)

PRAX Praxis Precision Medicines
$29.13 /

-0.48 (-1.62%)

PASG Passage Bio
$17.40 /

+0.65 (+3.88%)

KRTX Karuna Therapeutics
$119.05 /

+1.78 (+1.52%)

CERE Cerevel Therapeutics
$13.49 /

+1.12 (+9.05%)

BIIB Biogen
$276.92 /

+1.04 (+0.38%)

AVDL Avadel Pharmaceuticals
$9.00 /

+0.17 (+1.93%)

ZGNX Zogenix
$19.38 /

+0.19 (+0.99%)

PRAX Praxis Precision Medicines
$29.13 /

-0.48 (-1.62%)

PASG Passage Bio
$17.40 /

+0.65 (+3.88%)

BIIB Biogen
$276.92 /

+1.04 (+0.38%)

Conference/Events
Jefferies healthcare analysts to hold an analyst/industry conference call » 08:55
03/31/21
03/31
08:55
03/31/21
08:55
JAZZ

Jazz Pharmaceuticals

$166.55 /

-0.8 (-0.48%)

, GWPH

GW Pharmaceuticals

$217.64 /

-0.19 (-0.09%)

, GSK

GlaxoSmithKline

$36.38 /

-0.31 (-0.84%)

, ZGNX

Zogenix

$19.19 /

+0.67 (+3.62%)

, XENE

Xenon Pharmaceuticals

$17.34 /

+0.28 (+1.64%)

, MRNS

Marinus Pharmaceuticals

$14.32 /

-0.125 (-0.87%)

Healthcare Analysts Tsai…

Healthcare Analysts Tsai & Windley, along with Drs. Sullivan & Rao provide an expert update on Epilepsy on an Analyst/Industry conference call to be held on March 31 at 10 am.

ShowHide Related Items >><<
ZGNX Zogenix
$19.19 /

+0.67 (+3.62%)

XENE Xenon Pharmaceuticals
$17.34 /

+0.28 (+1.64%)

MRNS Marinus Pharmaceuticals
$14.32 /

-0.125 (-0.87%)

JAZZ Jazz Pharmaceuticals
$166.55 /

-0.8 (-0.48%)

GWPH GW Pharmaceuticals
$217.64 /

-0.19 (-0.09%)

GSK GlaxoSmithKline
$36.38 /

-0.31 (-0.84%)

JAZZ Jazz Pharmaceuticals
$166.55 /

-0.8 (-0.48%)

03/01/21 UBS
Jazz Pharmaceuticals price target raised to $228 from $174 at UBS
02/24/21 Cowen
Jazz Pharmaceuticals price target raised to $200 from $190 at Cowen
02/24/21 Jefferies
Jazz Pharmaceuticals price target raised to $214 from $209 at Jefferies
02/24/21 Piper Sandler
Jazz Pharmaceuticals price target raised to $205 from $175 at Piper Sandler
GWPH GW Pharmaceuticals
$217.64 /

-0.19 (-0.09%)

02/05/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $207 from $195 at H.C. Wainwright
02/04/21 SVB Leerink
GW Pharmaceuticals downgraded to Market Perform from Outperform at SVB Leerink
02/04/21
GW Pharmaceuticals downgraded to Neutral from Buy at Citi
02/04/21 H.C. Wainwright
GW Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
GSK GlaxoSmithKline
$36.38 /

-0.31 (-0.84%)

03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
03/23/21 SVB Leerink
GlaxoSmithKline downgraded to Market Perform from Outperform at SVB Leerink
03/08/21 JPMorgan
JPMorgan double downgrades AnaptysBio back to Underweight after trial miss
ZGNX Zogenix
$19.19 /

+0.67 (+3.62%)

02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
08/24/20 Raymond James
Zogenix initiated with a Market Perform at Raymond James
07/15/20 Stifel
Physician survey suggests Zogenix shares undervalued, says Stifel
XENE Xenon Pharmaceuticals
$17.34 /

+0.28 (+1.64%)

10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
07/21/20
Fly Intel: Top five analyst initiations
07/21/20 Needham
Xenon Pharmaceuticals initiated with a Buy at Needham
MRNS Marinus Pharmaceuticals
$14.32 /

-0.125 (-0.87%)

03/10/21 H.C. Wainwright
Marinus Pharmaceuticals price target raised to $38 from $35 at H.C. Wainwright
11/10/20 Cantor Fitzgerald
Marinus Pharmaceuticals price target raised to $27 from $8 at Cantor Fitzgerald
09/30/20 Truist
Marinus Pharmaceuticals initiated with a Buy at Truist
09/25/20 JMP Securities
Marinus Pharmaceuticals price target raised to $26 from $7 at JMP Securities
ZGNX Zogenix
$19.19 /

+0.67 (+3.62%)

XENE Xenon Pharmaceuticals
$17.34 /

+0.28 (+1.64%)

MRNS Marinus Pharmaceuticals
$14.32 /

-0.125 (-0.87%)

JAZZ Jazz Pharmaceuticals
$166.55 /

-0.8 (-0.48%)

GWPH GW Pharmaceuticals
$217.64 /

-0.19 (-0.09%)

GSK GlaxoSmithKline
$36.38 /

-0.31 (-0.84%)

  • 10
    Mar
  • 08
    Dec
  • 29
    May
GWPH GW Pharmaceuticals
$217.64 /

-0.19 (-0.09%)

GSK GlaxoSmithKline
$36.38 /

-0.31 (-0.84%)

ZGNX Zogenix
$19.19 /

+0.67 (+3.62%)

XENE Xenon Pharmaceuticals
$17.34 /

+0.28 (+1.64%)

MRNS Marinus Pharmaceuticals
$14.32 /

-0.125 (-0.87%)

JAZZ Jazz Pharmaceuticals
$166.55 /

-0.8 (-0.48%)

GSK GlaxoSmithKline
$36.38 /

-0.31 (-0.84%)

ZGNX Zogenix
$19.19 /

+0.67 (+3.62%)

GWPH GW Pharmaceuticals
$217.64 /

-0.19 (-0.09%)

Over a quarter ago
On The Fly
Fly Intel: Pre-market Movers » 09:05
03/10/21
03/10
09:05
03/10/21
09:05
AER

AerCap

$55.97 /

-1.54 (-2.68%)

, AFMD

Affimed

$5.47 /

+0.325 (+6.32%)

, MNOV

MediciNova

$5.61 /

+0.23 (+4.28%)

, UNFI

United Natural Foods

$30.36 /

-1.43 (-4.50%)

, BBW

Build-A-Bear

$7.16 /

-0.24 (-3.24%)

, OTRK

Ontrak

$28.49 /

+3.19 (+12.61%)

, CPB

Campbell Soup

$46.95 /

-0.315 (-0.67%)

, TUP

Tupperware Brands

$32.40 /

+0.58 (+1.82%)

, XM

Qualtrics

$37.07 /

+2.56 (+7.42%)

, GE

General Electric

$13.99 /

-0.18 (-1.27%)

, TPX

Tempur Sealy

$36.70 /

-0.39 (-1.05%)

, XENE

Xenon Pharmaceuticals

$20.04 /

+0.32 (+1.62%)

Check out this morning's…

ShowHide Related Items >><<
XM Qualtrics
$37.07 /

+2.56 (+7.42%)

XENE Xenon Pharmaceuticals
$20.04 /

+0.32 (+1.62%)

UNFI United Natural Foods
$30.36 /

-1.43 (-4.50%)

TUP Tupperware Brands
$32.40 /

+0.58 (+1.82%)

TPX Tempur Sealy
$36.70 /

-0.39 (-1.05%)

OTRK Ontrak
$28.49 /

+3.19 (+12.61%)

MNOV MediciNova
$5.61 /

+0.23 (+4.28%)

GE General Electric
$13.99 /

-0.18 (-1.27%)

CPB Campbell Soup
$46.95 /

-0.315 (-0.67%)

BBW Build-A-Bear
$7.16 /

-0.24 (-3.24%)

AFMD Affimed
$5.47 /

+0.325 (+6.32%)

AER AerCap
$55.97 /

-1.54 (-2.68%)

AER AerCap
$55.97 /

-1.54 (-2.68%)

03/09/21 Citi
General Electric deal with AerCap would be viewed positively, says Citi
03/08/21 Stephens
Stephens positive on AerCap reportedly buying GECAS
01/26/21 Cowen
AerCap price target raised to $54 from $50 at Cowen
12/21/20 Deutsche Bank
AerCap price target raised to $55 from $44 at Deutsche Bank
AFMD Affimed
$5.47 /

+0.325 (+6.32%)

MNOV MediciNova
$5.61 /

+0.23 (+4.28%)

03/10/21 Maxim
MediciNova initiated with a Buy at Maxim
03/10/21 Maxim
MediciNova initiated with a Buy at Maxim
UNFI United Natural Foods
$30.36 /

-1.43 (-4.50%)

02/19/21
Fly Intel: Top five analyst initiations
02/19/21 Seaport Global
United Natural Foods initiated with a Neutral at Seaport Global
01/28/21 MKM Partners
United Natural Foods price target raised to $36 from $26 at MKM Partners
01/28/21 Northcoast
United Natural Foods downgraded to Neutral from Buy at Northcoast
BBW Build-A-Bear
$7.16 /

-0.24 (-3.24%)

OTRK Ontrak
$28.49 /

+3.19 (+12.61%)

03/02/21 B. Riley
Ontrak price target lowered to $73 from $110 at B. Riley Securities
03/02/21 Cowen
Cowen downgrades Ontrak to Market Perform until visibility returns
03/02/21 Canaccord
Canaccord downgrades Ontrak after loss of largest customer
03/02/21 Cowen
Ontrak downgraded to Market Perform from Outperform at Cowen
CPB Campbell Soup
$46.95 /

-0.315 (-0.67%)

02/25/21 Deutsche Bank
Campbell Soup price target lowered to $50 from $52 at Deutsche Bank
01/12/21 Jefferies
Campbell Soup price target lowered to $54 from $58 at Jefferies
12/10/20 Credit Suisse
Campbell Soup price target lowered to $49 from $55 at Credit Suisse
10/19/20 Citi
Campbell Soup initiated with a Neutral at Citi
TUP Tupperware Brands
$32.40 /

+0.58 (+1.82%)

09/25/20 Citi
Tupperware Brands price target raised to $28 from $15 at Citi
09/24/20 DA Davidson
Tupperware can stabilize core business, grow organic sales, says DA Davidson
09/15/20
Fly Intel: Top five analyst initiations
09/15/20 DA Davidson
Tupperware Brands initiated with a Buy at DA Davidson
XM Qualtrics
$37.07 /

+2.56 (+7.42%)

03/10/21 BMO Capital
Qualtrics price target lowered to $45 from $52 at BMO Capital
03/10/21 Oppenheimer
Qualtrics price target lowered to $55 from $60 at Oppenheimer
03/10/21 Citi
Qualtrics price target lowered to $55 from $61 at Citi
03/10/21 Oppenheimer
Qualtrics should be bought on pullbacks after 'strong' Q4, says Oppenheimer
GE General Electric
$13.99 /

-0.18 (-1.27%)

03/04/21 Morgan Stanley
General Electric price target raised to $17 from $13 at Morgan Stanley
03/02/21 Barclays
Danaher started at Overweight at Barclays on GE biopharma business potential
TPX Tempur Sealy
$36.70 /

-0.39 (-1.05%)

03/10/21 Loop Capital
Tempur Sealy downgraded to Hold from Buy at Loop Capital
02/18/21 UBS
Tempur Sealy upgraded to Buy from Neutral at UBS
02/12/21 Truist
Tempur Sealy price target raised to $45 from $31 at Truist
01/26/21 Loop Capital
Tempur Sealy price target raised to $35 from $30 at Loop Capital
XENE Xenon Pharmaceuticals
$20.04 /

+0.32 (+1.62%)

10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
07/21/20
Fly Intel: Top five analyst initiations
07/21/20 Needham
Xenon Pharmaceuticals initiated with a Buy at Needham
XM Qualtrics
$37.07 /

+2.56 (+7.42%)

XENE Xenon Pharmaceuticals
$20.04 /

+0.32 (+1.62%)

UNFI United Natural Foods
$30.36 /

-1.43 (-4.50%)

TUP Tupperware Brands
$32.40 /

+0.58 (+1.82%)

TPX Tempur Sealy
$36.70 /

-0.39 (-1.05%)

OTRK Ontrak
$28.49 /

+3.19 (+12.61%)

GE General Electric
$13.99 /

-0.18 (-1.27%)

CPB Campbell Soup
$46.95 /

-0.315 (-0.67%)

BBW Build-A-Bear
$7.16 /

-0.24 (-3.24%)

AER AerCap
$55.97 /

-1.54 (-2.68%)

  • 10
    Mar
  • 13
    Jan
  • 28
    Jan
XM Qualtrics
$37.07 /

+2.56 (+7.42%)

UNFI United Natural Foods
$30.36 /

-1.43 (-4.50%)

GE General Electric
$13.99 /

-0.18 (-1.27%)

CPB Campbell Soup
$46.95 /

-0.315 (-0.67%)

AER AerCap
$55.97 /

-1.54 (-2.68%)

XM Qualtrics
$37.07 /

+2.56 (+7.42%)

UNFI United Natural Foods
$30.36 /

-1.43 (-4.50%)

TUP Tupperware Brands
$32.40 /

+0.58 (+1.82%)

TPX Tempur Sealy
$36.70 /

-0.39 (-1.05%)

OTRK Ontrak
$28.49 /

+3.19 (+12.61%)

MNOV MediciNova
$5.61 /

+0.23 (+4.28%)

CPB Campbell Soup
$46.95 /

-0.315 (-0.67%)

BBW Build-A-Bear
$7.16 /

-0.24 (-3.24%)

AER AerCap
$55.97 /

-1.54 (-2.68%)

XM Qualtrics
$37.07 /

+2.56 (+7.42%)

UNFI United Natural Foods
$30.36 /

-1.43 (-4.50%)

TUP Tupperware Brands
$32.40 /

+0.58 (+1.82%)

TPX Tempur Sealy
$36.70 /

-0.39 (-1.05%)

OTRK Ontrak
$28.49 /

+3.19 (+12.61%)

GE General Electric
$13.99 /

-0.18 (-1.27%)

CPB Campbell Soup
$46.95 /

-0.315 (-0.67%)

Syndicate
Xenon Pharmaceuticals 4.32M share Spot Secondary priced at $18.50 » 06:33
03/10/21
03/10
06:33
03/10/21
06:33
XENE

Xenon Pharmaceuticals

$20.04 /

+0.32 (+1.62%)

The deal size was…

The deal size was increased to $100M from $60M and priced below the last closing price of $20.04. Jefferies, Stifel and William Blair are acting as joint book running managers for the offering.

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$20.04 /

+0.32 (+1.62%)

XENE Xenon Pharmaceuticals
$20.04 /

+0.32 (+1.62%)

10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
07/21/20
Fly Intel: Top five analyst initiations
07/21/20 Needham
Xenon Pharmaceuticals initiated with a Buy at Needham
XENE Xenon Pharmaceuticals
$20.04 /

+0.32 (+1.62%)

  • 10
    Mar
XENE Xenon Pharmaceuticals
$20.04 /

+0.32 (+1.62%)

On The Fly
Fly Intel: After-Hours Movers » 18:29
03/09/21
03/09
18:29
03/09/21
18:29
OM

Outset Medical

$48.70 /

+1.835 (+3.92%)

, NARI

Inari Medical

$99.12 /

+8.96 (+9.94%)

, OTRK

Ontrak

$28.49 /

+3.19 (+12.61%)

, ABM

ABM

$47.36 /

-0.54 (-1.13%)

, LPRO

Open Lending

$34.69 /

+1.73 (+5.25%)

, EVRI

Everi Holdings

$14.52 /

+0.31 (+2.18%)

, APEI

American Public Education

$27.71 /

+0.4 (+1.46%)

, MDB

MongoDB

$310.95 /

+23.59 (+8.21%)

, MNOV

MediciNova

$5.61 /

+0.23 (+4.28%)

, CLNE

Clean Energy

$11.80 /

+1.1 (+10.28%)

, AVID

Avid Technology

$20.46 /

+1.4 (+7.35%)

, OSH

Oak Street Health

$53.55 /

+0.77 (+1.46%)

, HRB

H&R Block

$19.75 /

-0.37 (-1.84%)

, JNCE

Jounce Therapeutics

$11.86 /

-0.13 (-1.08%)

, XENE

Xenon Pharmaceuticals

$20.04 /

+0.32 (+1.62%)

, SONO

Sonos

$38.30 /

+2.5 (+6.98%)

Check out this evening's…

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$20.04 /

+0.32 (+1.62%)

SONO Sonos
$38.30 /

+2.5 (+6.98%)

OTRK Ontrak
$28.49 /

+3.19 (+12.61%)

OSH Oak Street Health
$53.55 /

+0.77 (+1.46%)

OM Outset Medical
$48.70 /

+1.835 (+3.92%)

NARI Inari Medical
$99.12 /

+8.96 (+9.94%)

MNOV MediciNova
$5.61 /

+0.23 (+4.28%)

MDB MongoDB
$310.95 /

+23.59 (+8.21%)

LPRO Open Lending
$34.69 /

+1.73 (+5.25%)

JNCE Jounce Therapeutics
$11.86 /

-0.13 (-1.08%)

HRB H&R Block
$19.75 /

-0.37 (-1.84%)

EVRI Everi Holdings
$14.52 /

+0.31 (+2.18%)

CLNE Clean Energy
$11.80 /

+1.1 (+10.28%)

AVID Avid Technology
$20.46 /

+1.4 (+7.35%)

APEI American Public Education
$27.71 /

+0.4 (+1.46%)

ABM ABM
$47.36 /

-0.54 (-1.13%)

OM Outset Medical
$48.70 /

+1.835 (+3.92%)

12/15/20 Oppenheimer
Oppenheimer starts Outset Medical at Perform, citing competition
12/15/20 Oppenheimer
Outset Medical initiated with a Perform at Oppenheimer
10/12/20
Fly Intel: Top five analyst initiations
10/12/20 Morgan Stanley
Outset Medical initiated with an Equal Weight at Morgan Stanley
NARI Inari Medical
$99.12 /

+8.96 (+9.94%)

01/21/21 BTIG
Inari Medical price target raised to $110 from $92 at BTIG
01/20/21 Wells Fargo
Inari Medical price target raised to $112 from $79 at Wells Fargo
12/15/20 Wells Fargo
Wells Fargo says Buy Inari Medical, Sell NuVasive in MedTech ratings shake-up
12/15/20 Wells Fargo
Inari Medical upgraded to Overweight from Equal Weight at Wells Fargo
OTRK Ontrak
$28.49 /

+3.19 (+12.61%)

03/02/21 B. Riley
Ontrak price target lowered to $73 from $110 at B. Riley Securities
03/02/21 Cowen
Cowen downgrades Ontrak to Market Perform until visibility returns
03/02/21 Canaccord
Canaccord downgrades Ontrak after loss of largest customer
03/02/21 Cowen
Ontrak downgraded to Market Perform from Outperform at Cowen
ABM ABM
$47.36 /

-0.54 (-1.13%)

01/06/21 CL King
ABM named best idea for 2021 amid 'misperception' at CL King
12/21/20 CL King
ABM price target raised to $48 from $45 at CL King
12/14/20 CL King
Adoption of ABM's EnhancedClean driving higher-margin growth, says CL King
09/17/20 Sidoti
ABM upgraded to Buy from Neutral at Sidoti
LPRO Open Lending
$34.69 /

+1.73 (+5.25%)

03/04/21 William Blair
Open Lending initiated with an Outperform at William Blair
02/10/21 Needham
Open Lending initiated with a Buy at Needham
01/20/21 DA Davidson
Open Lending price target raised to $45 from $31 at DA Davidson
01/04/21 Deutsche Bank
Open Lending named 'Catalyst Call: Buy Idea' at Deutsche Bank
EVRI Everi Holdings
$14.52 /

+0.31 (+2.18%)

02/18/21 BTIG
Everi Holdings price target raised to $21 from $16 at BTIG
01/26/21 Craig-Hallum
Everi Holdings price target raised to $20 from $13 at Craig-Hallum
01/19/21 Jefferies
Everi Holdings price target raised to $16 from $14 at Jefferies
12/09/20 Stifel
Everi Holdings resumed with a Buy at Stifel
APEI American Public Education
$27.71 /

+0.4 (+1.46%)

12/18/20 B. Riley
B. Riley starts 'compelling' American Public Education with Buy rating
12/18/20 B. Riley
American Public Education initiated with a Buy at B. Riley Securities
11/10/20 Barrington
American Public Education price target raised to $40 from $37 at Barrington
11/02/20 Sidoti
American Public Education upgraded to Buy from Neutral at Sidoti
MDB MongoDB
$310.95 /

+23.59 (+8.21%)

03/08/21 Morgan Stanley
Software industry rating raised to Attractive from In-Line at Morgan Stanley
02/23/21 Citi
MongoDB price target raised to $500 from $465 at Citi
01/19/21 Needham
MongoDB price target raised to $394 from $341 at Needham
01/15/21 Stifel
Elastic upgraded to Buy after licensing changes at Stifel
MNOV MediciNova
$5.61 /

+0.23 (+4.28%)

CLNE Clean Energy
$11.80 /

+1.1 (+10.28%)

02/11/21 Lake Street
Clean Energy price target raised to $27 from $9 at Lake Street
02/08/21 Craig-Hallum
Clean Energy price target raised to $25 from $12 at Craig-Hallum
02/03/21
Fly Intel: Top five analyst initiations
02/03/21 Credit Suisse
Clean Energy initiated with an Outperform at Credit Suisse
AVID Avid Technology
$20.46 /

+1.4 (+7.35%)

03/03/21 B. Riley
Avid Technology price target raised to $24 from $18 at B. Riley Securities
02/09/21 Northland
Avid Technology price target raised to $32 from $22 at Northland
12/31/20 B. Riley
Avid Technology price target raised to $18 from $13.50 at B. Riley Securities
10/29/20 B. Riley
Avid Technology price target raised to $13.50 from $12 at B. Riley Securities
OSH Oak Street Health
$53.55 /

+0.77 (+1.46%)

02/24/21 Canaccord
Canaccord starts Oak Street Health at Buy with $67 price target
02/24/21 Canaccord
Oak Street Health initiated with a Buy at Canaccord
02/17/21 Piper Sandler
Oak Street Health price target raised to $69 from $59 at Piper Sandler
01/28/21 Wolfe Research
Oak Street Health initiated with an Outperform at Wolfe Research
HRB H&R Block
$19.75 /

-0.37 (-1.84%)

10/30/20 BTIG
BTIG thinks those looking to potentially short Square, H&R Block should wait
09/03/20 BMO Capital
H&R Block price target lowered to $17 from $19 at BMO Capital
09/01/20 BTIG
H&R Block's tax season distorted by pandemic, say BTIG
07/15/20 Northcoast
H&R Block upgraded to Buy from Neutral at Northcoast
JNCE Jounce Therapeutics
$11.86 /

-0.13 (-1.08%)

02/26/21 H.C. Wainwright
Jounce Therapeutics price target raised to $15 from $11 at H.C. Wainwright
12/04/20 H.C. Wainwright
Jounce Therapeutics assumed with a Buy at H.C. Wainwright
11/10/20 Roth Capital
Jounce Therapeutics price target lowered to $15 from $28 at Roth Capital
11/03/20 Raymond James
Jounce downgraded to Market Perform from Strong Buy at Raymond James
XENE Xenon Pharmaceuticals
$20.04 /

+0.32 (+1.62%)

10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
07/21/20
Fly Intel: Top five analyst initiations
07/21/20 Needham
Xenon Pharmaceuticals initiated with a Buy at Needham
SONO Sonos
$38.30 /

+2.5 (+6.98%)

03/05/21 Morgan Stanley
Sonos analyst day to be positive catalyst for shares, says Morgan Stanley
02/11/21 Goldman Sachs
Sonos upgraded to Neutral from Sell at Goldman Sachs
02/11/21 Morgan Stanley
Sonos price target raised to $45 from $35 at Morgan Stanley
02/03/21 Morgan Stanley
Morgan Stanley raises price target on 'top small cap' pick Sonos to $35
XENE Xenon Pharmaceuticals
$20.04 /

+0.32 (+1.62%)

SONO Sonos
$38.30 /

+2.5 (+6.98%)

OTRK Ontrak
$28.49 /

+3.19 (+12.61%)

OSH Oak Street Health
$53.55 /

+0.77 (+1.46%)

OM Outset Medical
$48.70 /

+1.835 (+3.92%)

NARI Inari Medical
$99.12 /

+8.96 (+9.94%)

MDB MongoDB
$310.95 /

+23.59 (+8.21%)

LPRO Open Lending
$34.69 /

+1.73 (+5.25%)

JNCE Jounce Therapeutics
$11.86 /

-0.13 (-1.08%)

HRB H&R Block
$19.75 /

-0.37 (-1.84%)

EVRI Everi Holdings
$14.52 /

+0.31 (+2.18%)

CLNE Clean Energy
$11.80 /

+1.1 (+10.28%)

AVID Avid Technology
$20.46 /

+1.4 (+7.35%)

APEI American Public Education
$27.71 /

+0.4 (+1.46%)

ABM ABM
$47.36 /

-0.54 (-1.13%)

  • 10
    Mar
  • 10
    Mar
  • 25
    Feb
  • 11
    Feb
  • 10
    Dec
  • 03
    Dec
  • 03
    Dec
  • 15
    Sep
  • 06
    Aug
  • 18
    Jun
  • 22
    May
SONO Sonos
$38.30 /

+2.5 (+6.98%)

SONO Sonos
$38.30 /

+2.5 (+6.98%)

OTRK Ontrak
$28.49 /

+3.19 (+12.61%)

OSH Oak Street Health
$53.55 /

+0.77 (+1.46%)

OM Outset Medical
$48.70 /

+1.835 (+3.92%)

MNOV MediciNova
$5.61 /

+0.23 (+4.28%)

MDB MongoDB
$310.95 /

+23.59 (+8.21%)

HRB H&R Block
$19.75 /

-0.37 (-1.84%)

EVRI Everi Holdings
$14.52 /

+0.31 (+2.18%)

AVID Avid Technology
$20.46 /

+1.4 (+7.35%)

ABM ABM
$47.36 /

-0.54 (-1.13%)

SONO Sonos
$38.30 /

+2.5 (+6.98%)

OTRK Ontrak
$28.49 /

+3.19 (+12.61%)

OSH Oak Street Health
$53.55 /

+0.77 (+1.46%)

MDB MongoDB
$310.95 /

+23.59 (+8.21%)

LPRO Open Lending
$34.69 /

+1.73 (+5.25%)

CLNE Clean Energy
$11.80 /

+1.1 (+10.28%)

Syndicate
Xenon Pharmaceuticals $60M Spot Secondary re-offered at $18.50 » 16:27
03/09/21
03/09
16:27
03/09/21
16:27
XENE

Xenon Pharmaceuticals

$20.04 /

+0.32 (+1.62%)

Jefferies, Stifel and…

Jefferies, Stifel and William Blair are acting as joint book running managers for the offering.

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$20.04 /

+0.32 (+1.62%)

XENE Xenon Pharmaceuticals
$20.04 /

+0.32 (+1.62%)

10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
07/21/20
Fly Intel: Top five analyst initiations
07/21/20 Needham
Xenon Pharmaceuticals initiated with a Buy at Needham
XENE Xenon Pharmaceuticals
$20.04 /

+0.32 (+1.62%)

Syndicate
Xenon Pharmaceuticals files to sell common stock, no amount given » 16:05
03/09/21
03/09
16:05
03/09/21
16:05
XENE

Xenon Pharmaceuticals

$19.98 /

+0.26 (+1.32%)

Jefferies, Stifel, and…

Jefferies, Stifel, and William Blair are acting as joint book-running managers for the offering. Needham & Company and Wedbush PacGrow are acting as co-managers for the offering.

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$19.98 /

+0.26 (+1.32%)

XENE Xenon Pharmaceuticals
$19.98 /

+0.26 (+1.32%)

10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
07/21/20
Fly Intel: Top five analyst initiations
07/21/20 Needham
Xenon Pharmaceuticals initiated with a Buy at Needham
XENE Xenon Pharmaceuticals
$19.98 /

+0.26 (+1.32%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.